{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:13:22Z","timestamp":1791296002097,"version":"4.1.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00401-009-0501-8","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T20:05:42Z","timestamp":1234987542000},"page":"115-130","source":"Crossref","is-referenced-by-count":245,"title":["Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies"],"prefix":"10.1007","volume":"118","author":[{"given":"Tamas","family":"Revesz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blas","family":"Frangione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agueda","family":"Rostagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ghiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"501_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-003-0783-1","volume":"107","author":"H Akiyama","year":"2004","unstructured":"Akiyama H, Kondo H, Arai T, Ikeda K, Kato M, Iseki E, Schwab C, McGeer PL (2004) Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol 107:53\u201358. doi: 10.1007\/s00401-003-0783-1","journal-title":"Acta Neuropathol"},{"key":"501_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005072-199804000-00008","volume":"57","author":"NC Alonzo","year":"1998","unstructured":"Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM (1998) Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 57:353\u2013359. doi: 10.1097\/00005072-199804000-00008","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0046-8177(97)90196-9","volume":"28","author":"KH Anders","year":"1997","unstructured":"Anders KH, Wang ZZ, Kornfeld M, Gray F, Soontornniyomkij V, Reed LA, Hart MN, Menchine M, Secor DL, Vinters HV (1997) Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. Hum Pathol 28:1237\u20131246. doi: 10.1016\/S0046-8177(97)90196-9","journal-title":"Hum Pathol"},{"key":"501_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology\u2014a pilot study. Acta Neuropathol 107:83\u201390. doi: 10.1007\/s00401-003-0796-9","journal-title":"Acta Neuropathol"},{"key":"501_CR5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-004-0822-6","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Lintner F, Jellinger KA (2004) Amyloid beta peptide 1\u201342 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol 107:283\u2013291. doi: 10.1007\/s00401-004-0822-6","journal-title":"Acta Neuropathol"},{"key":"501_CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10611860290031831","volume":"10","author":"JR Bading","year":"2002","unstructured":"Bading JR, Yamada S, Mackic JB, Kirkman L, Miller C, Calero M, Ghiso J, Frangione B, Zlokovic BV (2002) Brain clearance of Alzheimer\u2019s amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J Drug Target 10:359\u2013368. doi: 10.1080\/10611860290031831","journal-title":"J Drug Target"},{"key":"501_CR7","first-page":"351","volume":"148","author":"MD Benson","year":"1996","unstructured":"Benson MD (1996) Leptomeningeal amyloid and variant transthyretins. Am J Pathol 148:351\u2013354","journal-title":"Am J Pathol"},{"key":"501_CR8","first-page":"564","volume":"14","author":"C Bergeron","year":"1987","unstructured":"Bergeron C, Ranalli PJ, Miceli PN (1987) Amyloid angiopathy in Alzheimer\u2019s disease. Can J Neurol Sci 14:564\u2013569","journal-title":"Can J Neurol Sci"},{"key":"501_CR9","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","volume":"131","author":"D Boche","year":"2008","unstructured":"Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA (2008) Consequence of Abeta immunization on the vasculature of human Alzheimer\u2019s disease brain. Brain 131:3299\u20133310. doi: 10.1093\/brain\/awn261","journal-title":"Brain"},{"key":"501_CR10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1161591","volume":"321","author":"DL Brody","year":"2008","unstructured":"Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ, Holtzman DM (2008) Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321:1221\u20131224. doi: 10.1126\/science.1161591","journal-title":"Science"},{"key":"501_CR11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1749-6632.2000.tb06381.x","volume":"903","author":"P Burgermeister","year":"2000","unstructured":"Burgermeister P, Calhoun ME, Winkler DT, Jucker M (2000) Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models. Ann N Y Acad Sci 903:307\u2013316. doi: 10.1111\/j.1749-6632.2000.tb06381.x","journal-title":"Ann N Y Acad Sci"},{"key":"501_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jnen\/59.9.768","volume":"59","author":"D Cadavid","year":"2000","unstructured":"Cadavid D, Mena H, Koeller K, Frommelt RA (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59:768\u2013773","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR13","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","volume":"96","author":"ME Calhoun","year":"1999","unstructured":"Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 96:14088\u201314093. doi: 10.1073\/pnas.96.24.14088","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2990.2003.00457.x","volume":"29","author":"K Chalmers","year":"2003","unstructured":"Chalmers K, Wilcock GK, Love S (2003) APOE epsilon 4 influences the pathological phenotype of Alzheimer\u2019s disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol 29:231\u2013238. doi: 10.1046\/j.1365-2990.2003.00457.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"501_CR15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1110837","volume":"308","author":"B Chesebro","year":"2005","unstructured":"Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435\u20131439. doi: 10.1126\/science.1110837","journal-title":"Science"},{"key":"501_CR16","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285\u20133290. doi: 10.1172\/JCI25247","journal-title":"J Clin Invest"},{"key":"501_CR17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer\u2019s disease increases beta-protein production. Nature 360:672\u2013674. doi: 10.1038\/360672a0","journal-title":"Nature"},{"key":"501_CR18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","volume":"10","author":"LH Connors","year":"2003","unstructured":"Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE (2003) Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 10:160\u2013184","journal-title":"Amyloid"},{"key":"501_CR19","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1074\/jbc.M312946200","volume":"279","author":"J Davis","year":"2004","unstructured":"Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, Zlokovic BV, Van Nostrand WE (2004) Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 279:20296\u201320306. doi: 10.1074\/jbc.M312946200","journal-title":"J Biol Chem"},{"key":"501_CR20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, Du YS, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907\u2013913. doi: 10.1038\/nm890","journal-title":"Nat Med"},{"key":"501_CR21","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease. Science 295:2264\u20132267. doi: 10.1126\/science.1067568","journal-title":"Science"},{"key":"501_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1471-4159.2002.00889.x","volume":"81","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Parsadanian M, O\u2019dell MA, Foss EM, Paul SM, Holtzman DM (2002) Plaque-associated disruption of CSF and plasma amyloid-beta (A\u03b2) equilibrium in a mouse model of Alzheimer\u2019s disease. J Neurochem 81:229\u2013236. doi: 10.1046\/j.1471-4159.2002.00889.x","journal-title":"J Neurochem"},{"key":"501_CR23","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/124.12.2383","volume":"124","author":"B Dermaut","year":"2001","unstructured":"Dermaut B, Kumar-Singh S, De Jonghe C, Cruts M, Lofgren A, Lubke U, Cras P, Dom R, De Deyn PP, Martin JJ, Van Broeckhoven C (2001) Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer\u2019s disease due to a novel presenilin 1 mutation. Brain 124:2383\u20132392. doi: 10.1093\/brain\/124.12.2383","journal-title":"Brain"},{"key":"501_CR24","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","volume":"46","author":"RJ Ellis","year":"1996","unstructured":"Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: the CERAD experience, Part XV. Neurology 46:1592\u20131596","journal-title":"Neurology"},{"key":"501_CR25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ana.10810","volume":"55","author":"JA Eng","year":"2004","unstructured":"Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250\u2013256. doi: 10.1002\/ana.10810","journal-title":"Ann Neurol"},{"key":"501_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2990.2000.00239.x","volume":"26","author":"MM Esiri","year":"2000","unstructured":"Esiri MM, Carter J, Ironside JW (2000) Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol 26:273\u2013284. doi: 10.1046\/j.1365-2990.2000.00239.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"501_CR27","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/jnnp.49.11.1221","volume":"49","author":"MM Esiri","year":"1986","unstructured":"Esiri MM, Wilcock GK (1986) Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 49:1221\u20131226. doi: 10.1136\/jnnp.49.11.1221","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"501_CR28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00005072-199411000-00011","volume":"53","author":"J Frackowiak","year":"1994","unstructured":"Frackowiak J, Zoltowska A, Wisniewski HM (1994) Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 53:637\u2013645. doi: 10.1097\/00005072-199411000-00011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"501_CR29","first-page":"36","volume":"8","author":"B Frangione","year":"2001","unstructured":"Frangione B, Revesz T, Vidal R, Holton J, Lashley T, Houlden H, Wood N, Rostagno A, Plant G, Ghiso J (2001) Familial cerebral amyloid angiopathy related to stroke and dementia. Amyloid 8(Suppl 1):36\u201342","journal-title":"Amyloid"},{"key":"501_CR30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1471-4159.1996.67020880.x","volume":"67","author":"JF Ghersi-Egea","year":"1996","unstructured":"Ghersi-Egea JF, Gorevic PD, Ghiso J, Frangione B, Patlak CS, Fenstermacher JD (1996) Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem 67:880\u2013883","journal-title":"J Neurochem"},{"key":"501_CR31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1073\/pnas.93.2.744","volume":"93","author":"B Ghetti","year":"1996","unstructured":"Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR, Tagliavini F (1996) Vascular variant of prion protein cerebral amyloidosis with tau- positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744\u2013748. doi: 10.1073\/pnas.93.2.744","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR32","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1097\/00001756-199611040-00040","volume":"7","author":"JR Ghilardi","year":"1996","unstructured":"Ghilardi JR, Catton M, Stimson ER, Rogers S, Walker LC, Maggio JE, Mantyh PW (1996) Intra-arterial infusion of [125I]A beta 1\u201340 labels amyloid deposits in the aged primate brain in vivo. NeuroReport 7:2607\u20132611. doi: 10.1097\/00001756-199611040-00040","journal-title":"NeuroReport"},{"key":"501_CR33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(97)00400-6","volume":"408","author":"J Ghiso","year":"1997","unstructured":"Ghiso J, Calero M, Matsubara E, Governale S, Chuba J, Beavis R, Wisniewski T, Frangione B (1997) Alzheimer\u2019s soluble amyloid beta is a normal component of human urine. FEBS Lett 408:105\u2013108. doi: 10.1016\/S0014-5793(97)00400-6","journal-title":"FEBS Lett"},{"key":"501_CR34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0169-409X(02)00149-7","volume":"54","author":"J Ghiso","year":"2002","unstructured":"Ghiso J, Frangione B (2002) Amyloidosis and Alzheimer\u2019s disease. Adv Drug Deliv Rev 54:1539\u20131551. doi: 10.1016\/S0169-409X(02)00149-7","journal-title":"Adv Drug Deliv Rev"},{"key":"501_CR35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1042\/bj2720827","volume":"272","author":"J Ghiso","year":"1990","unstructured":"Ghiso J, Haltia M, Prelli F, Novello J, Frangione B (1990) Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 272:827\u2013830","journal-title":"Biochem J"},{"key":"501_CR36","doi-asserted-by":"crossref","first-page":"43909","DOI":"10.1074\/jbc.M105956200","volume":"276","author":"J Ghiso","year":"2001","unstructured":"Ghiso J, Holton J, Miravalle L, Calero M, Lashley T, Vidal R, Houlden H, Wood N, Neubert T, Rostagno A, Plant G, Revesz T, Frangione B (2001) Systemic amyloid deposits in familial British dementia. J Biol Chem 276:43909\u201343914. doi: 10.1074\/jbc.M105956200","journal-title":"J Biol Chem"},{"key":"501_CR37","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1073\/pnas.83.9.2974","volume":"83","author":"J Ghiso","year":"1986","unstructured":"Ghiso J, Jensson O, Frangione B (1986) Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci USA 83:2974\u20132978. doi: 10.1073\/pnas.83.9.2974","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1750-3639.2006.tb00563.x","volume":"16","author":"J Ghiso","year":"2006","unstructured":"Ghiso J, Rostagno A, Tomidokoro Y, Lashley T, Bojsen-Moller M, Braendgaard H, Plant G, Holton J, Lal R, Revesz T, Frangione B (2006) Genetic alterations of the BRI2 gene: familial British and Danish dementias. Brain Pathol 16:71\u201379. doi: 10.1111\/j.1750-3639.2006.tb00563.x","journal-title":"Brain Pathol"},{"key":"501_CR39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.1009","volume":"49","author":"TJ Grabowski","year":"2001","unstructured":"Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49:697\u2013705. doi: 10.1002\/ana.1009","journal-title":"Ann Neurol"},{"key":"501_CR40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410180110","volume":"18","author":"F Gray","year":"1985","unstructured":"Gray F, Dubas F, Roullet E, Escourolle R (1985) Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 18:54\u201359. doi: 10.1002\/ana.410180110","journal-title":"Ann Neurol"},{"key":"501_CR41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.58.11.1587","volume":"58","author":"SM Greenberg","year":"2002","unstructured":"Greenberg SM (2002) Cerebral amyloid angiopathy and dementia: two amyloids are worse than one. Neurology 58:1587\u20131588","journal-title":"Neurology"},{"key":"501_CR42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","volume":"38","author":"SM Greenberg","year":"1995","unstructured":"Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT (1995) Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38:254\u2013259. doi: 10.1002\/ana.410380219","journal-title":"Ann Neurol"},{"key":"501_CR43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.50.4.961","volume":"50","author":"SM Greenberg","year":"1998","unstructured":"Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, Hyman BT, Rebeck GW (1998) Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50:961\u2013965","journal-title":"Neurology"},{"key":"501_CR44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1381612033391676","volume":"9","author":"LB Hersh","year":"2003","unstructured":"Hersh LB (2003) Peptidases, proteases and amyloid beta-peptide catabolism. Curr Pharm Des 9:449\u2013454. doi: 10.2174\/1381612033391676","journal-title":"Curr Pharm Des"},{"key":"501_CR45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","volume":"16","author":"MC Herzig","year":"2006","unstructured":"Herzig MC, Van Nostrand WE, Jucker M (2006) Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 16:40\u201354. doi: 10.1111\/j.1750-3639.2006.tb00560.x","journal-title":"Brain Pathol"},{"key":"501_CR46","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nn1302","volume":"7","author":"MC Herzig","year":"2004","unstructured":"Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, Danner S, Abramowski D, Sturchler-Pierrat C, Burki K, van Duinen SG, Maat-Schieman ML, Staufenbiel M, Mathews PM, Jucker M (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7:954\u2013960. doi: 10.1038\/nn1302","journal-title":"Nat Neurosci"},{"key":"501_CR47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9440(10)63993-4","volume":"158","author":"JL Holton","year":"2001","unstructured":"Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G, Houlden H, Ayling H, Martinian L, Anderton BH, Wood NW, Vidal R, Plant G, Frangione B, Revesz T (2001) Regional distribution of amyloid-BRI deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 158:515\u2013526","journal-title":"Am J Pathol"},{"key":"501_CR48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jnen\/61.3.254","volume":"61","author":"JL Holton","year":"2002","unstructured":"Holton JL, Lashley T, Ghiso J, Braendgaard H, Vidal R, Guerin CJ, Gibb G, Hanger DP, Rostagno A, Anderton BH, Strand C, Ayling H, Plant G, Frangione B, Bojsen-Moller M, Revesz T (2002) Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 61:254\u2013267","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1385\/JMN:23:3:247","volume":"23","author":"DM Holtzman","year":"2004","unstructured":"Holtzman DM (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J Mol Neurosci 23:247\u2013254. doi: 10.1385\/JMN:23:3:247","journal-title":"J Mol Neurosci"},{"key":"501_CR50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F","volume":"48","author":"H Houlden","year":"2000","unstructured":"Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, Wood NW, Kumar-Singh S, Geddes J, Swash M, Scaravilli F, Holton JL, Lashley T, Tomita T, Hashimoto T, Verkkoniemi A, Kalimo H, Somer M, Paetau A, Martin JJ, Van Broeckhoven C, Golde T, Hardy J, Haltia M, Revesz T (2000) Variant Alzheimer\u2019s disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 48:806\u2013808. doi: 10.1002\/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F","journal-title":"Ann Neurol"},{"key":"501_CR51","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2008.12.095","volume":"379","author":"E Ihse","year":"2008","unstructured":"Ihse E, Stangou AJ, Heaton ND, O\u2019Grady J, Ybo A, Hellman U, Edvinsson S, Westermark P (2008) Proportion of wild-type transthyretin in truncated compared to full-length ATTR: an analysis on transplanted transthyretin T60A amyloidosis patients. Biochem Biophys Res Commun 379:846\u2013850","journal-title":"Biochem Biophys Res Commun"},{"key":"501_CR52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410370305","volume":"37","author":"T Iwatsubo","year":"1995","unstructured":"Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y (1995) Amyloid beta protein (A beta) deposition: a beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol 37:294\u2013299. doi: 10.1002\/ana.410370305","journal-title":"Ann Neurol"},{"key":"501_CR53","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1468-1331.2007.01880.x","volume":"14","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA, Lauda F, Attems J (2007) Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol 14:923\u2013928. doi: 10.1111\/j.1468-1331.2007.01880.x","journal-title":"Eur J Neurol"},{"key":"501_CR54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0169-328X(95)00180-Z","volume":"35","author":"RN Kalaria","year":"1996","unstructured":"Kalaria RN, Premkumar DR, Pax AB, Cohen DL, Lieberburg I (1996) Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer\u2019s disease. Brain Res Mol Brain Res 35:58\u201368. doi: 10.1016\/0169-328X(95)00180-Z","journal-title":"Brain Res Mol Brain Res"},{"key":"501_CR55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1568013033483267","volume":"3","author":"RN Kalaria","year":"2003","unstructured":"Kalaria RN, Thomas A, Oakley A, Ince P, Tamaoka A, Mori H, Kenny RA, Ballard C (2003) Cerebrovascular amyloidosis and dementia. Curr Med Chem Immun Endocr Metab Agents 3:317\u2013327","journal-title":"Curr Med Chem Immun Endocr Metab Agents"},{"key":"501_CR56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0197-4580(95)02061-6","volume":"17","author":"T Kawarabayashi","year":"1996","unstructured":"Kawarabayashi T, Shoji M, Sato M, Sasaki A, Ho L, Eckman CB, Prada CM, Younkin SG, Kobayashi T, Tada N, Matsubara E, Iizuka T, Harigaya Y, Kasai K, Hirai S (1996) Accumulation of beta-amyloid fibrils in pancreas of transgenic mice. Neurobiol Aging 17:215\u2013222. doi: 10.1016\/0197-4580(95)02061-6","journal-title":"Neurobiol Aging"},{"key":"501_CR57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, Dickson DW, Golde T, McGowan E (2007) Abeta40 inhibits amyloid deposition in vivo. J Neurosci 27:627\u2013633. doi: 10.1523\/JNEUROSCI.4849-06.2007","journal-title":"J Neurosci"},{"key":"501_CR58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jnen\/60.3.274","volume":"60","author":"EY Kimchi","year":"2001","unstructured":"Kimchi EY, Kajdasz S, Bacskai BJ, Hyman BT (2001) Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy. J Neuropathol Exp Neurol 60:274\u2013279","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR59","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","volume":"76","author":"FC Lam","year":"2001","unstructured":"Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB (2001) beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121\u20131128. doi: 10.1046\/j.1471-4159.2001.00113.x","journal-title":"J Neurochem"},{"key":"501_CR60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0304-3940(94)90463-4","volume":"168","author":"L Lannfelt","year":"1994","unstructured":"Lannfelt L, Bogdanovic N, Appelgren H, Axelman K, Lilius L, Hansson G, Schenk D, Hardy J, Winblad B (1994) Amyloid precursor protein mutation causes Alzheimer\u2019s disease in a Swedish family. Neurosci Lett 168:254\u2013256. doi: 10.1016\/0304-3940(94)90463-4","journal-title":"Neurosci Lett"},{"key":"501_CR61","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2990.2006.00747.x","volume":"32","author":"T Lashley","year":"2006","unstructured":"Lashley T, Holton JL, Verbeek MM, Rostagno A, Bojsen-Moller M, David G, Van HJ, Braendgaard H, Plant G, Frangione B, Ghiso J, Revesz T (2006) Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study. Neuropathol Appl Neurobiol 32:492\u2013504. doi: 10.1111\/j.1365-2990.2006.00747.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"501_CR62","doi-asserted-by":"crossref","unstructured":"Lashley T, Revesz T, Plant G, Bandopadhyay R, Lees AJ, Frangione B, Wood NW, de Silva R, Ghiso J, Rostagno A, Holton JL (2008) Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease. Neuropathol Appl Neurobiol 34:492\u2013505","DOI":"10.1111\/j.1365-2990.2008.00935.x"},{"key":"501_CR63","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","volume":"248","author":"E Levy","year":"1990","unstructured":"Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer\u2019s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124\u20131126. doi: 10.1126\/science.2111584","journal-title":"Science"},{"key":"501_CR64","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.169.5.1771","volume":"169","author":"E Levy","year":"1989","unstructured":"Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B (1989) Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 169:1771\u20131778. doi: 10.1084\/jem.169.5.1771","journal-title":"J Exp Med"},{"key":"501_CR65","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/13506120600877003","volume":"13","author":"JJ Liepnieks","year":"2006","unstructured":"Liepnieks JJ, Wilson DL, Benson MD (2006) Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Amyloid 13:170\u2013177. doi: 10.1080\/13506120600877003","journal-title":"Amyloid"},{"key":"501_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jnnp.2003.034249","volume":"75","author":"S Love","year":"2004","unstructured":"Love S (2004) Contribution of cerebral amyloid angiopathy to Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 75:1\u20134. doi: 10.1136\/jnnp.2003.034249","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"501_CR67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1750-3639.1996.tb00794.x","volume":"6","author":"ML Maat-Schieman","year":"1996","unstructured":"Maat-Schieman ML, van Duinen SG, Bornebroek M, Haan J, Roos RA (1996) Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II\u2014a review of histopathological aspects. Brain Pathol 6:115\u2013120. doi: 10.1111\/j.1750-3639.1996.tb00794.x","journal-title":"Brain Pathol"},{"key":"501_CR68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1471-4159.1998.70010210.x","volume":"70","author":"JB Mackic","year":"1998","unstructured":"Mackic JB, Weiss MH, Miao W, Kirkman E, Ghiso J, Calero M, Bading J, Frangione B, Zlokovic BV (1998) Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer\u2019s amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy. J Neurochem 70:210\u2013215","journal-title":"J Neurochem"},{"key":"501_CR69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.25.2.120","volume":"25","author":"TI Mandybur","year":"1975","unstructured":"Mandybur TI (1975) The incidence of cerebral amyloid angiopathy in Alzheimer\u2019s disease. Neurology 25:120\u2013126","journal-title":"Neurology"},{"key":"501_CR70","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0024-3205(94)00331-9","volume":"55","author":"LM Maness","year":"1994","unstructured":"Maness LM, Banks WA, Podlisny MB, Selkoe DJ, Kastin AJ (1994) Passage of human amyloid beta-protein 1\u201340 across the murine blood-brain barrier. Life Sci 55:1643\u20131650. doi: 10.1016\/0024-3205(94)00331-9","journal-title":"Life Sci"},{"key":"501_CR71","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0002-9440(10)64688-3","volume":"158","author":"DM Mann","year":"2001","unstructured":"Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T (2001) Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer\u2019s disease. Am J Pathol 158:2165\u20132175","journal-title":"Am J Pathol"},{"key":"501_CR72","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1046\/j.1471-4159.1997.69051995.x","volume":"69","author":"CL Martel","year":"1997","unstructured":"Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, McComb JG, Frangione B, Ghiso J, Zlokovic BV (1997) Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer\u2019s amyloid beta. J Neurochem 69:1995\u20132004","journal-title":"J Neurochem"},{"key":"501_CR73","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI115118","volume":"87","author":"CP Maury","year":"1991","unstructured":"Maury CP (1991) Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest 87:1195\u20131199. doi: 10.1172\/JCI115118","journal-title":"J Clin Invest"},{"key":"501_CR74","first-page":"558","volume":"70","author":"CP Maury","year":"1994","unstructured":"Maury CP, Nurmiaho-Lassila EL, Rossi H (1994) Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab Invest 70:558\u2013564","journal-title":"Lab Invest"},{"key":"501_CR75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-94-017-1007-7_5","volume-title":"Cerebral amyloid angiopathy in Alzheimer\u2019s disease and related disorders","author":"MO McCarron","year":"2000","unstructured":"McCarron MO, Nicoll JAR (2000) ApoE genotype ain relation to sporadic and Alzheimer-related CAA. In: Verbeek MM, de Waal RMW, Vinters HV (eds) Cerebral amyloid angiopathy in Alzheimer\u2019s disease and related disorders. Kluwer, Dordrecht, pp 81\u2013102"},{"key":"501_CR76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47:191\u2013199. doi: 10.1016\/j.neuron.2005.06.030","journal-title":"Neuron"},{"key":"501_CR77","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/brain\/123.5.975","volume":"123","author":"S Mead","year":"2000","unstructured":"Mead S, James-Galton M, Revesz T, Doshi RB, Harwood G, Pan EL, Ghiso J, Frangione B, Plant G (2000) Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. Brain 123:975\u2013991. doi: 10.1093\/brain\/123.5.975","journal-title":"Brain"},{"key":"501_CR78","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","volume":"18","author":"JS Miners","year":"2008","unstructured":"Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S (2008) Abeta-degrading enzymes in Alzheimer\u2019s disease. Brain Pathol 18:240\u2013252. doi: 10.1111\/j.1750-3639.2008.00132.x","journal-title":"Brain Pathol"},{"key":"501_CR79","doi-asserted-by":"crossref","first-page":"27110","DOI":"10.1016\/S0021-9258(19)61486-9","volume":"275","author":"L Miravalle","year":"2000","unstructured":"Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, Frangione B, Ghiso J (2000) Substitutions at codon 22 of Alzheimer\u2019s A\u03b2 peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 275:27110\u201327116","journal-title":"J Biol Chem"},{"key":"501_CR80","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0197-4580(01)00317-7","volume":"23","author":"OR Monro","year":"2002","unstructured":"Monro OR, Mackic JB, Yamada S, Segal MB, Ghiso J, Maurer C, Calero M, Frangione B, Zlokovic BV (2002) Substitution at codon 22 reduces clearance of Alzheimer\u2019s amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging 23:405\u2013412. doi: 10.1016\/S0197-4580(01)00317-7","journal-title":"Neurobiol Aging"},{"key":"501_CR81","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1023\/A:1021679817756","volume":"27","author":"L Morelli","year":"2002","unstructured":"Morelli L, Llovera R, Ibendahl S, Castano EM (2002) The degradation of amyloid beta as a therapeutic strategy in Alzheimer\u2019s disease and cerebrovascular amyloidoses. Neurochem Res 27:1387\u20131399. doi: 10.1023\/A:1021679817756","journal-title":"Neurochem Res"},{"key":"501_CR82","doi-asserted-by":"crossref","first-page":"56004","DOI":"10.1074\/jbc.M407283200","volume":"279","author":"L Morelli","year":"2004","unstructured":"Morelli L, Llovera RE, Mathov I, Lue LF, Frangione B, Ghiso J, Castano EM (2004) Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid-\u03b2 vasculotropic variants and reduced activity in cerebral amyloid angiopathy. J Biol Chem 279:56004\u201356013. doi: 10.1074\/jbc.M407283200","journal-title":"J Biol Chem"},{"key":"501_CR83","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jnen\/63.7.679","volume":"63","author":"RE Mrak","year":"2004","unstructured":"Mrak RE, Griffin WS (2004) Trisomy 21 and the brain. J Neuropathol Exp Neurol 63:679\u2013685","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1:345\u2013347. doi: 10.1038\/ng0892-345","journal-title":"Nat Genet"},{"key":"501_CR85","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1073\/pnas.91.18.8378","volume":"91","author":"J Naslund","year":"1994","unstructured":"Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, Silberring J, Gandy SE, Winblad B, Greengard P (1994) Relative abundance of Alzheimer A\u03b2 amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 91:8378\u20138382. doi: 10.1073\/pnas.91.18.8378","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR86","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.10040","volume":"50","author":"R Natte","year":"2001","unstructured":"Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG (2001) Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 50:765\u2013772. doi: 10.1002\/ana.10040","journal-title":"Ann Neurol"},{"key":"501_CR87","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004010051121","volume":"98","author":"R Natte","year":"1999","unstructured":"Natte R, Yamaguchi H, Maat-Schieman ML, Prins FA, Neeskens P, Roos RA, van Duinen SG (1999) Ultrastructural evidence of early non-fibrillar A\u03b242 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type. Acta Neuropathol 98:577\u2013582. doi: 10.1007\/s004010051121","journal-title":"Acta Neuropathol"},{"key":"501_CR88","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.410410607","volume":"41","author":"JA Nicoll","year":"1997","unstructured":"Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV (1997) High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41:716\u2013721. doi: 10.1002\/ana.410410607","journal-title":"Ann Neurol"},{"key":"501_CR89","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neurobiolaging.2004.02.003","volume":"25","author":"JA Nicoll","year":"2004","unstructured":"Nicoll JA, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO (2004) Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer\u2019s disease. Pro-CAA position statement. Neurobiol Aging 25:589\u2013597. doi: 10.1016\/j.neurobiolaging.2004.02.003","journal-title":"Neurobiol Aging"},{"key":"501_CR90","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.410430124","volume":"43","author":"D Nochlin","year":"1998","unstructured":"Nochlin D, Bird TD, Nemens EJ, Ball MJ, Sumi SM (1998) Amyloid angiopathy in a Volga German family with Alzheimer\u2019s disease and a presenilin-2 mutation (N141I). Ann Neurol 43:131\u2013135. doi: 10.1002\/ana.410430124","journal-title":"Ann Neurol"},{"key":"501_CR91","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM200001273420403","volume":"342","author":"HC O\u2019Donnell","year":"2000","unstructured":"O\u2019Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, Ikeda D, Greenberg SM (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342:240\u2013245. doi: 10.1056\/NEJM200001273420403","journal-title":"N Engl J Med"},{"key":"501_CR92","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1212\/WNL.47.1.190","volume":"47","author":"JM Olichney","year":"1996","unstructured":"Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease and Lewy body variant. Neurology 47:190\u2013196","journal-title":"Neurology"},{"key":"501_CR93","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archneur.1995.00540310076019","volume":"52","author":"JM Olichney","year":"1995","unstructured":"Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ (1995) Cerebral infarction in Alzheimer\u2019s disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 52:702\u2013708","journal-title":"Arch Neurol"},{"key":"501_CR94","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-008-0394-y","volume":"116","author":"C Paquet","year":"2008","unstructured":"Paquet C, Privat N, Kaci R, Polivka M, Dupont O, Haik S, Laplanche JL, Hauw JJ, Gray F (2008) Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 116:567\u2013573. doi: 10.1007\/s00401-008-0394-y","journal-title":"Acta Neuropathol"},{"key":"501_CR95","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1021\/bi8006324","volume":"47","author":"MG Paulick","year":"2008","unstructured":"Paulick MG, Bertozzi CR (2008) The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry 47:6991\u20137000. doi: 10.1021\/bi8006324","journal-title":"Biochemistry"},{"key":"501_CR96","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.410410305","volume":"41","author":"RB Petersen","year":"1997","unstructured":"Petersen RB, Goren H, Cohen M, Richardson SL, Tresser N, Lynn A, Gali M, Estes M, Gambetti P (1997) Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 41:307\u2013313. doi: 10.1002\/ana.410410305","journal-title":"Ann Neurol"},{"key":"501_CR97","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/WNL.58.11.1629","volume":"58","author":"LA Pfeifer","year":"2002","unstructured":"Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58:1629\u20131634","journal-title":"Neurology"},{"key":"501_CR98","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","volume":"298","author":"M Pfeifer","year":"2002","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M (2002) Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298:1379. doi: 10.1126\/science.1078259","journal-title":"Science"},{"key":"501_CR99","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1017\/CBO9780511526886.015","volume-title":"The neuropathology of dementia","author":"GT Plant","year":"2004","unstructured":"Plant GT, Ghiso J, Holton JL, Frangione B, Revesz T (2004) Familial and sporadic cerebral amyloid angiopathies associated with dementia and the BRI dementias. In: Esiri MM, Lee VMY, Trojanowski JQ (eds) The neuropathology of dementia. Cambridge University Press, Cambridge, pp 330\u2013352"},{"key":"501_CR100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/brain\/113.3.721","volume":"113","author":"GT Plant","year":"1990","unstructured":"Plant GT, Revesz T, Barnard RO, Harding AE, Gautier-Smith PC (1990) Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain 113:721\u2013747. doi: 10.1093\/brain\/113.3.721","journal-title":"Brain"},{"key":"501_CR101","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/nbdi.1999.0238","volume":"6","author":"JF Poduslo","year":"1999","unstructured":"Poduslo JF, Curran GL, Sanyal B, Selkoe DJ (1999) Receptor-mediated transport of human amyloid beta-protein 1\u201340 and 1\u201342 at the blood-brain barrier. Neurobiol Dis 6:190\u2013199. doi: 10.1006\/nbdi.1999.0238","journal-title":"Neurobiol Dis"},{"key":"501_CR102","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1523\/JNEUROSCI.5426-06.2007","volume":"27","author":"CM Prada","year":"2007","unstructured":"Prada CM, Garcia-Alloza M, Betensky RA, Zhang-Nunes SX, Greenberg SM, Bacskai BJ, Frosch MP (2007) Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci 27:1973\u20131980. doi: 10.1523\/JNEUROSCI.5426-06.2007","journal-title":"J Neurosci"},{"key":"501_CR103","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1073\/pnas.80.2.539","volume":"80","author":"M Pras","year":"1983","unstructured":"Pras M, Prelli F, Franklin EC, Frangione B (1983) Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci USA 80:539\u2013542. doi: 10.1073\/pnas.80.2.539","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0006-291X(90)91274-V","volume":"170","author":"F Prelli","year":"1990","unstructured":"Prelli F, Levy E, van Duinen SG, Bots GT, Luyendijk W, Frangione B (1990) Expression of a normal and variant Alzheimer\u2019s beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. Biochem Biophys Res Commun 170:301\u2013307. doi: 10.1016\/0006-291X(90)91274-V","journal-title":"Biochem Biophys Res Commun"},{"key":"501_CR105","first-page":"2083","volume":"148","author":"DR Premkumar","year":"1996","unstructured":"Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN (1996) Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer\u2019s disease. Am J Pathol 148:2083\u20132095","journal-title":"Am J Pathol"},{"key":"501_CR106","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","volume":"344","author":"SB Prusiner","year":"2001","unstructured":"Prusiner SB (2001) Shattuck lecture\u2014neurodegenerative diseases and prions. N Engl J Med 344:1516\u20131526. doi: 10.1056\/NEJM200105173442006","journal-title":"N Engl J Med"},{"key":"501_CR107","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1073\/pnas.0502066102","volume":"102","author":"A Quist","year":"2005","unstructured":"Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci USA 102:10427\u201310432. doi: 10.1073\/pnas.0502066102","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR108","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jnen\/62.9.885","volume":"62","author":"T Revesz","year":"2003","unstructured":"Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL (2003) Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62:885\u2013898","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004010050970","volume":"97","author":"T Revesz","year":"1999","unstructured":"Revesz T, Holton JL, Doshi B, Anderton BH, Scaravilli F, Plant GT (1999) Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation. Acta Neuropathol 97:170\u2013176. doi: 10.1007\/s004010050970","journal-title":"Acta Neuropathol"},{"key":"501_CR110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.2002.tb00449.x","volume":"12","author":"T Revesz","year":"2002","unstructured":"Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, Frangione B (2002) Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 12:343\u2013357","journal-title":"Brain Pathol"},{"key":"501_CR111","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/oso\/9780198566618.003.0006","volume-title":"The neurobiology of Alzheimer\u2019s disease","author":"A Rostagno","year":"2007","unstructured":"Rostagno A, Lal R, Ghiso J (2007) Protein misfolding, aggregation, and fibril formation: common features of cerebral and non-cerebral amyloid diseases. In: Dawbarn D, Allen S (eds) The neurobiology of Alzheimer\u2019s disease. Oxford University Press, Oxford, pp 133\u2013160"},{"key":"501_CR112","doi-asserted-by":"crossref","first-page":"49782","DOI":"10.1074\/jbc.M206448200","volume":"277","author":"A Rostagno","year":"2002","unstructured":"Rostagno A, Revesz T, Lashley T, Tomidokoro Y, Magnotti L, Braendgaard H, Plant G, Bojsen-Moller M, Holton J, Frangione B, Ghiso J (2002) Complement activation in chromosome 13 dementias. Similarities with Alzheimer\u2019s disease. J Biol Chem 277:49782\u201349790. doi: 10.1074\/jbc.M206448200","journal-title":"J Biol Chem"},{"key":"501_CR113","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00018-005-5092-5","volume":"62","author":"A Rostagno","year":"2005","unstructured":"Rostagno A, Tomidokoro Y, Lashley T, Ng D, Plant G, Holton J, Frangione B, Revesz T, Ghiso J (2005) Chromosome 13 dementias. Cell Mol Life Sci 62:1814\u20131825. doi: 10.1007\/s00018-005-5092-5","journal-title":"Cell Mol Life Sci"},{"key":"501_CR114","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Le MN, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, FREBOURG T, Campion D (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24\u201326. doi: 10.1038\/ng1718","journal-title":"Nat Genet"},{"key":"501_CR115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/brain\/awh379","volume":"128","author":"NJ Scolding","year":"2005","unstructured":"Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S (2005) A\u03b2-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500\u2013515. doi: 10.1093\/brain\/awh379","journal-title":"Brain"},{"key":"501_CR116","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","volume":"32","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Clearing the brain\u2019s amyloid cobwebs. Neuron 32:177\u2013180. doi: 10.1016\/S0896-6273(01)00475-5","journal-title":"Neuron"},{"key":"501_CR117","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81:741\u2013766","journal-title":"Physiol Rev"},{"key":"501_CR118","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/359325a0","volume":"359","author":"P Seubert","year":"1992","unstructured":"Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C (1992) Isolation and quantification of soluble Alzheimer\u2019s beta-peptide from biological fluids. Nature 359:325\u2013327. doi: 10.1038\/359325a0","journal-title":"Nature"},{"key":"501_CR119","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer\u2019s amyloid-\u03b2 (1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489\u20131499. doi: 10.1172\/JCI10498","journal-title":"J Clin Invest"},{"key":"501_CR120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1439760","volume":"258","author":"M Shoji","year":"1992","unstructured":"Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai XD, McKay DM, Tintner R, Frangione B (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258:126\u2013129. doi: 10.1126\/science.1439760","journal-title":"Science"},{"key":"501_CR121","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"DA Snowdon","year":"1997","unstructured":"Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277:813\u2013817. doi: 10.1001\/jama.277.10.813","journal-title":"JAMA"},{"key":"501_CR122","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0006-3495(94)80591-0","volume":"67","author":"SW Snyder","year":"1994","unstructured":"Snyder SW, Ladror US, Wade WS, Wang GT, Barrett LW, Matayoshi ED, Huffaker HJ, Krafft GA, Holzman TF (1994) Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J 67:1216\u20131228. doi: 10.1016\/S0006-3495(94)80591-0","journal-title":"Biophys J"},{"key":"501_CR123","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00005072-199801000-00009","volume":"57","author":"TL Tekirian","year":"1998","unstructured":"Tekirian TL, Saido TC, Markesbery WR, Russell MJ, Wekstein DR, Patel E, Geddes JW (1998) N-terminal heterogeneity of parenchymal and cerebrovascular A beta deposits. J Neuropathol Exp Neurol 57:76\u201394. doi: 10.1097\/00005072-199801000-00009","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR124","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"DR Thal","year":"2003","unstructured":"Thal DR, Ghebremedhin E, Orantes M, Wiestler OD (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287\u20131301","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282\u2013293","journal-title":"J Neuropathol Exp Neurol"},{"key":"501_CR126","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115:599\u2013609. doi: 10.1007\/s00401-008-0366-2","journal-title":"Acta Neuropathol"},{"key":"501_CR127","doi-asserted-by":"crossref","first-page":"36883","DOI":"10.1074\/jbc.M504038200","volume":"280","author":"Y Tomidokoro","year":"2005","unstructured":"Tomidokoro Y, Lashley T, Rostagno A, Neubert TA, Bojsen-Moller M, Braendgaard H, Plant G, Holton J, Frangione B, Revesz T, Ghiso J (2005) Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan and A\u03b2) in the absence of compact plaques. J Biol Chem 280:36883\u201336894. doi: 10.1074\/jbc.M504038200","journal-title":"J Biol Chem"},{"key":"501_CR128","doi-asserted-by":"crossref","unstructured":"Tomidokoro Y, Rostagno A, Greenberg SM, Frangione B, Rebeck WG, Ghiso J (2004) Biochemical analysis of A beta amyloid deposits in the Iowa variant of Alzheimer\u2019s disease. Neurobiol Aging 25:S38. doi: 10.1016\/S0197-4580(04)80125-8","DOI":"10.1016\/S0197-4580(04)80125-8"},{"key":"501_CR129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","volume":"63","author":"T Tomiyama","year":"2008","unstructured":"Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, Takuma H, Kuwano R, Imagawa M, Ataka S, Wada Y, Yoshioka E, Nishizaki T, Watanabe Y, Mori H (2008) A new amyloid beta variant favoring oligomerization in Alzheimer\u2019s-type dementia. Ann Neurol 63:377\u2013387. doi: 10.1002\/ana.21321","journal-title":"Ann Neurol"},{"key":"501_CR130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1532-5415.1981.tb01757.x","volume":"29","author":"M Tomonaga","year":"1981","unstructured":"Tomonaga M (1981) Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 29:151\u2013157","journal-title":"J Am Geriatr Soc"},{"key":"501_CR131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.2002.tb04799.x","volume":"977","author":"KP Townsend","year":"2002","unstructured":"Townsend KP, Obregon D, Quadros A, Patel N, Volmar C, Paris D, Mullan M (2002) Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad Sci 977:65\u201376","journal-title":"Ann N Y Acad Sci"},{"key":"501_CR132","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00401-006-0162-9","volume":"113","author":"D Trembath","year":"2007","unstructured":"Trembath D, Ervin JF, Broom L, Szymanski M, Welsh-Bohmer K, Pieper C, Hulette CM (2007) The distribution of cerebrovascular amyloid in Alzheimer\u2019s disease varies with ApoE genotype. Acta Neuropathol 113:23\u201331. doi: 10.1007\/s00401-006-0162-9","journal-title":"Acta Neuropathol"},{"key":"501_CR133","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9440(10)64644-5","volume":"157","author":"J Dorpe Van","year":"2000","unstructured":"Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den HC MERCKENM, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 157:1283\u20131298","journal-title":"Am J Pathol"},{"key":"501_CR134","doi-asserted-by":"crossref","first-page":"32860","DOI":"10.1074\/jbc.M104135200","volume":"276","author":"WE Nostrand Van","year":"2001","unstructured":"Van Nostrand WE, Melchor JP, Cho HS, Greenberg SM, Rebeck GW (2001) Pathogenic effects of D23 N Iowa mutant amyloid beta -protein. J Biol Chem 276:32860\u201332866. doi: 10.1074\/jbc.M104135200","journal-title":"J Biol Chem"},{"key":"501_CR135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.molmed.2005.08.004","volume":"11","author":"ER Vardy","year":"2005","unstructured":"Vardy ER, Catto AJ, Hooper NM (2005) Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer\u2019s disease. Trends Mol Med 11:464\u2013472. doi: 10.1016\/j.molmed.2005.08.004","journal-title":"Trends Mol Med"},{"key":"501_CR136","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s004010050944","volume":"96","author":"MM Verbeek","year":"1998","unstructured":"Verbeek MM, Otte-Holler I, Veerhuis R, Ruiter DJ, de Waal RM (1998) Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer\u2019s disease. Acta Neuropathol 96:628\u2013636. doi: 10.1007\/s004010050944","journal-title":"Acta Neuropathol"},{"key":"501_CR137","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1750-3639.2008.00164.x","volume":"19","author":"R Vidal","year":"2009","unstructured":"Vidal R, Barbeito AG, Miravalle L, Ghetti B (2009) Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol 19:58\u201368. doi: 10.1111\/j.1750-3639.2008.00164.x","journal-title":"Brain Pathol"},{"key":"501_CR138","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/21637","volume":"399","author":"R Vidal","year":"1999","unstructured":"Vidal R, Frangione B, Rostagno A, Mead S, Revesz T, Plant G, Ghiso J (1999) A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399:776\u2013781. doi: 10.1038\/21637","journal-title":"Nature"},{"key":"501_CR139","first-page":"361","volume":"148","author":"R Vidal","year":"1996","unstructured":"Vidal R, Garzuly F, Budka H, Lalowski M, Linke RP, Brittig F, Frangione B, Wisniewski T (1996) Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G). Am J Pathol 148:361\u2013366","journal-title":"Am J Pathol"},{"key":"501_CR140","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1073\/pnas.080076097","volume":"97","author":"R Vidal","year":"2000","unstructured":"Vidal R, Revesz T, Rostagno A, Kim E, Holton JL, Bek T, Bojsen-Moller M, Braendgaard H, Plant G, Ghiso J, Frangione B (2000) A decamer duplication in the 3\u2019 region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 97:4920\u20134925. doi: 10.1073\/pnas.080076097","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR141","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/j.1471-4159.1993.tb09841.x","volume":"61","author":"C Vigo-Pelfrey","year":"1993","unstructured":"Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB (1993) Characterization of beta-amyloid peptide from human cerebrospinal fluid. J Neurochem 61:1965\u20131968. doi: 10.1111\/j.1471-4159.1993.tb09841.x","journal-title":"J Neurochem"},{"key":"501_CR142","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.STR.18.2.311","volume":"18","author":"HV Vinters","year":"1987","unstructured":"Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18:311\u2013324","journal-title":"Stroke"},{"key":"501_CR143","first-page":"924","volume":"14","author":"HV Vinters","year":"1983","unstructured":"Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14:924\u2013928","journal-title":"II. The distribution of amyloid vascular changes. Stroke"},{"key":"501_CR144","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s004010050793","volume":"95","author":"HV Vinters","year":"1998","unstructured":"Vinters HV, Natte R, Maat-Schieman ML, van Duinen SG, Hegeman-Kleinn I, Welling-Graafland C, Haan J, Roos RA (1998) Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol 95:235\u2013244. doi: 10.1007\/s004010050793","journal-title":"Acta Neuropathol"},{"key":"501_CR145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-94-017-1007-7_8","volume-title":"Cerebral Amyloid Angiopathy in Alzheimer\u2019s Disease and Related Disorders","author":"HV Vinters","year":"2000","unstructured":"Vinters HV, Vonsattel JP (2000) Neuropathologic features and grading of Alzheimer-related and sporadic CAA. In: Verbeek MM, de Waal RMW, Vinters HV (eds) Cerebral Amyloid Angiopathy in Alzheimer\u2019s Disease and Related Disorders. Kluwer, Dordrecht, pp 137\u2013155"},{"key":"501_CR146","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.410300503","volume":"30","author":"JP Vonsattel","year":"1991","unstructured":"Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30:637\u2013649. doi: 10.1002\/ana.410300503","journal-title":"Ann Neurol"},{"key":"501_CR147","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-0173(97)00017-9","volume":"25","author":"LC Walker","year":"1997","unstructured":"Walker LC (1997) Animal models of cerebral beta-amyloid angiopathy. Brain Res Brain Res Rev 25:70\u201384. doi: 10.1016\/S0165-0173(97)00017-9","journal-title":"Brain Res Brain Res Rev"},{"key":"501_CR148","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.drudis.2006.08.004","volume":"11","author":"YJ Wang","year":"2006","unstructured":"Wang YJ, Zhou HD, Zhou XF (2006) Clearance of amyloid-beta in Alzheimer\u2019s disease: progress, problems and perspectives. Drug Discov Today 11:931\u2013938. doi: 10.1016\/j.drudis.2006.08.004","journal-title":"Drug Discov Today"},{"key":"501_CR149","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","volume":"153","author":"RO Weller","year":"1998","unstructured":"Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE (1998) Cerebral amyloid angiopathy\u2014amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s disease. Am J Pathol 153:725\u2013733","journal-title":"Am J Pathol"},{"key":"501_CR150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Brain Pathol 18:253\u2013266. doi: 10.1111\/j.1750-3639.2008.00133.x","journal-title":"Brain Pathol"},{"key":"501_CR151","doi-asserted-by":"crossref","unstructured":"Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, Morgan D (2004) Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 1:24. doi: 10.1186\/1742-2094-1-24","DOI":"10.1186\/1742-2094-1-24"},{"key":"501_CR152","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1523\/JNEUROSCI.21-05-01619.2001","volume":"21","author":"DT Winkler","year":"2001","unstructured":"Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, Wiederhold KH, Tolnay M, Staufenbiel M, Jucker M (2001) Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 21:1619\u20131627","journal-title":"J Neurosci"},{"key":"501_CR153","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/brain\/63.3.237","volume":"63","author":"C Worster-Drought","year":"1940","unstructured":"Worster-Drought C, Greenfield JG, McMenemey WH (1940) A form of familial presenile dementia with spastic paralysis (including the pathological examination of a case). Brain 63:237\u2013254. doi: 10.1093\/brain\/63.3.237","journal-title":"Brain"},{"key":"501_CR154","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/brain\/67.1.38","volume":"67","author":"C Worster-Drought","year":"1944","unstructured":"Worster-Drought C, Greenfield JG, McMenemey WH (1944) A form of familial presenile dementia with spastic paralysis. Brain 67:38\u201343. doi: 10.1093\/brain\/67.1.38","journal-title":"Brain"},{"key":"501_CR155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2002.tb04797.x","volume":"977","author":"M Yamada","year":"2002","unstructured":"Yamada M (2002) Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci 977:37\u201344","journal-title":"Ann N Y Acad Sci"},{"key":"501_CR156","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.STR.27.7.1155","volume":"27","author":"M Yamada","year":"1996","unstructured":"Yamada M, Itoh Y, Shintaku M, Kawamura J, Jensson O, Thorsteinsson L, Suematsu N, Matsushita M, Otomo E (1996) Immune reactions associated with cerebral amyloid angiopathy. Stroke 27:1155\u20131162","journal-title":"Stroke"},{"key":"501_CR157","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.10452","volume":"28","author":"M Yazaki","year":"2003","unstructured":"Yazaki M, Liepnieks JJ, Kincaid JC, Benson MD (2003) Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid. Muscle Nerve 28:438\u2013442. doi: 10.1002\/mus.10452","journal-title":"Muscle Nerve"},{"key":"501_CR158","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1750-3639.2006.tb00559.x","volume":"16","author":"SX Zhang-Nunes","year":"2006","unstructured":"Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, Frosch MP, Greenberg SM (2006) The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 16:30\u201339. doi: 10.1111\/j.1750-3639.2006.tb00559.x","journal-title":"Brain Pathol"},{"key":"501_CR159","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0169-409X(02)00150-3","volume":"54","author":"BV Zlokovic","year":"2002","unstructured":"Zlokovic BV (2002) Vascular disorder in Alzheimer\u2019s disease: role in pathogenesis of dementia and therapeutic targets. Adv Drug Deliv Rev 54:1553\u20131559. doi: 10.1016\/S0169-409X(02)00150-3","journal-title":"Adv Drug Deliv Rev"},{"key":"501_CR160","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1006\/bbrc.1993.2582","volume":"197","author":"BV Zlokovic","year":"1993","unstructured":"Zlokovic BV, Ghiso J, Mackic JB, McComb JG, Weiss MH, Frangione B (1993) Blood-brain barrier transport of circulating Alzheimer\u2019s amyloid beta. Biochem Biophys Res Commun 197:1034\u20131040. doi: 10.1006\/bbrc.1993.2582","journal-title":"Biochem Biophys Res Commun"},{"key":"501_CR161","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","volume":"93","author":"BV Zlokovic","year":"1996","unstructured":"Zlokovic BV, Martel CL, Matsubara E, McComb JG, Zheng G, McCluskey RT, Frangione B, Ghiso J (1996) Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci USA 93:4229\u20134234. doi: 10.1073\/pnas.93.9.4229","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR162","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/77397","volume":"6","author":"BV Zlokovic","year":"2000","unstructured":"Zlokovic BV, Yamada S, Holtzman D, Ghiso J, Frangione B (2000) Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat Med 6:718\u2013719. doi: 10.1038\/77397","journal-title":"Nat Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-009-0501-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-009-0501-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-009-0501-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T18:51:04Z","timestamp":1710096664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-009-0501-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1007\/s00401-009-0501-8","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]}}}